Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

No Message Exposure (Control Condition) clinical trials

1 of 1 indexed No Message Exposure (Control Condition) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

No Message Exposure (Control Condition): 1 US clinical trial tracked, 1 recruiting.

No Message Exposure (Control Condition) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Georgia, running 1 of these trials.

Enrollment posture brief

Registry condition no-message-exposure-control-condition

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

No Message Exposure (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near No Message Exposure (Control Condition)

No Message Exposure (Control Condition) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for No Message Exposure (Control Condition) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. No Message Exposure (Control Condition) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on No Message Exposure (Control Condition) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Exposure to Anti-Vaping Messages (no message exposure) Behavioral
1 trials
Exposure to Anti-Vaping Messages (flavor-specific themes then generic themes) Behavioral
1 trials
Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes) Behavioral
1 trials

US sites by state

Facility locations filed on No Message Exposure (Control Condition) trials. A trial with sites in several states counts in each.

Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this No Message Exposure (Control Condition) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 No Message Exposure (Control Condition) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Georgia sponsors the most No Message Exposure (Control Condition) trials on record, review their full trial history before evaluating a specific study. See University of Georgia's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This No Message Exposure (Control Condition) condition card totals 1 registered trials; most-linked intervention Exposure to Anti-Vaping Messages (no message exposure); top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.